ESR2 and renal cell adenocarcinoma: Results from human clinical data indicated that there was higher ERβ expression in tumors at later stages or higher grades and that the increased ERβ expression was associated with a worse survival and a lower disease-free survival for RCC patients [77,78,79,80].